Skip to search formSkip to main contentSkip to account menu

Fosinopril

Known as: (2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid, (2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid, L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, (1(S*(R*)),2alpha,4beta)- 
A phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As an ester prodrug, fosinopril is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Aim:  To investigate the effect of leflunomide for treatment of immunoglobulin A (IgA) nephropathy. 
2006
2006
We aimed to test if fosinopril reduces urinary protein excretion and alleviates renal tubular damage in normotensive children… 
2005
2005
Background and Purpose— Elevated urinary albumin excretion (UAE) is associated with an increased carotid intima-media thickness… 
Highly Cited
2001
Highly Cited
2001
The objective of this study was to delineate the transepithelial transport mechanisms of fosinopril in cultured cell lines… 
Highly Cited
2000
Highly Cited
2000
Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of recurrent myocardial infarction in patients with left… 
1996
1996
Platelets are intimately involved in atherosclerosis, and hypertension is a known risk factor for coronary artery disease. The…